These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9495877)
1. Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology. Bausch SB; Esteb TM; Terman GW; Chavkin C J Pharmacol Exp Ther; 1998 Mar; 284(3):1147-55. PubMed ID: 9495877 [TBL] [Abstract][Full Text] [Related]
2. The delta opioid receptor agonist, SNC80, has complex, dose-dependent effects on pilocarpine-induced seizures in Sprague-Dawley rats. Bausch SB; Garland JP; Yamada J Brain Res; 2005 May; 1045(1-2):38-44. PubMed ID: 15910761 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous excitatory currents and kappa-opioid receptor inhibition in dentate gyrus are increased in the rat pilocarpine model of temporal lobe epilepsy. Simmons ML; Terman GW; Chavkin C J Neurophysiol; 1997 Oct; 78(4):1860-8. PubMed ID: 9325355 [TBL] [Abstract][Full Text] [Related]
4. Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors. Loacker S; Sayyah M; Wittmann W; Herzog H; Schwarzer C Brain; 2007 Apr; 130(Pt 4):1017-28. PubMed ID: 17347252 [TBL] [Abstract][Full Text] [Related]
5. Kappa opioid control of seizures produced by a virus in an animal model. Solbrig MV; Adrian R; Baratta J; Lauterborn JC; Koob GF Brain; 2006 Mar; 129(Pt 3):642-54. PubMed ID: 16399805 [TBL] [Abstract][Full Text] [Related]
6. mu-Opioids disinhibit and kappa-opioids inhibit serotonin efflux in the dorsal raphe nucleus. Tao R; Auerbach SB Brain Res; 2005 Jul; 1049(1):70-9. PubMed ID: 15935332 [TBL] [Abstract][Full Text] [Related]
7. Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism. Kapusta DR; Obih JC J Pharmacol Exp Ther; 1995 Apr; 273(1):199-205. PubMed ID: 7714767 [TBL] [Abstract][Full Text] [Related]
9. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats. Bileviciute-Ljungar I; Spetea M Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967 [TBL] [Abstract][Full Text] [Related]
10. Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat. Gu B; Fraser MO; Thor KB; Dolber PC J Urol; 2004 Jan; 171(1):472-7. PubMed ID: 14665958 [TBL] [Abstract][Full Text] [Related]
11. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists. Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity. Tu B; Jiao Y; Herzog H; Nadler JV Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162 [TBL] [Abstract][Full Text] [Related]
13. Newly generated granule cells show rapid neuroplastic changes in the adult rat dentate gyrus during the first five days following pilocarpine-induced seizures. Shapiro LA; Figueroa-Aragon S; Ribak CE Eur J Neurosci; 2007 Aug; 26(3):583-92. PubMed ID: 17686039 [TBL] [Abstract][Full Text] [Related]
14. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. Tao R; Auerbach SB J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635 [TBL] [Abstract][Full Text] [Related]
15. Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy. Adolfo Argañaraz G; Regina Perosa S; Cristina Lencioni E; Bader M; Abrão Cavalheiro E; da Graça Naffah-Mazzacoratti M; Pesquero JB; Antônio Silva J Brain Res; 2004 Jul; 1013(1):30-9. PubMed ID: 15196965 [TBL] [Abstract][Full Text] [Related]
16. [Mossy fiber sprouting and synapse formation in the dentate gyrus of temporal lobe epilepsy rats induced by pilocarpine]. Li GL; Zhang N; Li J; Zhu DT; Wu ZG; Xiao B Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):424-8. PubMed ID: 16134595 [TBL] [Abstract][Full Text] [Related]
17. Prolonged infusion of tetrodotoxin does not block mossy fiber sprouting in pilocarpine-treated rats. Buckmaster PS Epilepsia; 2004 May; 45(5):452-8. PubMed ID: 15101826 [TBL] [Abstract][Full Text] [Related]
18. Plastic changes and disease-modifying effects of scopolamine in the pilocarpine model of epilepsy in rats. Pereira HA; Benassi SK; Mello LE Epilepsia; 2005; 46 Suppl 5():118-24. PubMed ID: 15987265 [TBL] [Abstract][Full Text] [Related]
19. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus. Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735 [TBL] [Abstract][Full Text] [Related]
20. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C. Bian JS; Wang HX; Zhang WM; Wong TM Br J Pharmacol; 1998 Jun; 124(3):600-6. PubMed ID: 9647487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]